Cigna sells its life, accident and allied businesses to Chubb for US $ 5.75 billion
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
It is a recombinant nanoparticle protein-based vaccine
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
Subscribe To Our Newsletter & Stay Updated